Abstract:Background: Co-infection of hepatitis virus is common in human immunodeficiency virus (HIV) infected adults in China. But little is known about hepatitis virus co-infection in pediatric HIV-infected subjects. The study aimed to investigate the impact of hepatitis B virus (HBV) and/or hepatitis C virus (HCV) co-infection and highly active antiretroviral therapy (HAART) on liver function of pediatric HIV-infected subjects. Materials and Methods: A cohort study including 101 pediatric HIV-infected subjects with HBV/HCV co-infection and 44 pediatric comparators with HIV mono-infection was carried out in Henan Province of China from September 2011 to September 2012. All patients received HAART for 1-year. HBV and HCV infection was determined by antibody tests. HIV RNA load, CD4+ T-cell counts and liver function were determined before and after HAART. The Student's t-test or a one-way ANOVA was used for normally distributed values and A Mann-Whitney U-test was performed for values without normal distribution using SPSS statistical package 18.0 (SPSS Inc.). Results: After HAART for 1-year, the median levels of viral load were decreased to lower limit of detection in 90.34% pediatric HIV-infected subjects with/without HBV/HCV co-infection (P < 0.001), and CD4+ T-cell counts increased significantly (P < 0.001). Compared with the pre-HAART, mean level of alanine aminotransferase (ALT) in each group had a significant increase after HAART (P < 0.01). The mean levels of ALT and aspartate aminotransferase (AST) in nevirapine (NVP) based HAART group increased significantly after HAART (P < 0.01). Mean change values of ALT and AST were significantly higher in the NVP based regimen group than in the efavirenz (EFV) based regimen group (P < 0.01). For HIV/HBV/HCV co-infected patients, mean change values of ALT and AST in NVP-based HAART group was significantly higher than that in EFV-based HAART group (P < 0.01). Conclusion: Highly active antiretroviral therapy can damage liver function in pediatric HIV-infected subjects, especially in those with HBV/HCV co-infection. NVP was more harmful to liver function of pediatric HIV-infected subjects than EFV.

OL-005 A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts in HCV/HIV Coinfected Patients

[Highly Active Antiretroviral Therapy on Liver Function in HIV-positive Children with HBV/HCV Co-Infection].

The effect of different HAART regimens on liver function and HIV load of HIV infected children with HCV co-infection

A Higher Correlation Of Hcv Core Antigen With Cd4+T Cell Counts Compared With Hcv Rna In Hcv/Hiv-1 Coinfected Patients

Efficacy and safety of efavirenz-based regimens in human immunodeficiency virus/hepatitis C virus co-infected patients

Clinical study of hyperlipidemia and fatty liver disease in patients receiving HAART

An Observation on the Effectiveness of the Patient with Chronic Hepatitis C by Combining Interferon and Ribavirin

Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: therapeutic outcomes and the prognostic role of natural killer cells

The Effect of Highly Active Antiretroviral Therapy on Liver Function in Human Immunodeficiency Virus-Infected Pediatric Patients with or Without Hepatitis Virus Co-Infection

Patients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China: An observational study.

Effectiveness of HCV Core Antigen and RNA Quantification in HCV-infected and HCV/HIV-1-coinfected Patients.

Free Paper Presentation 2 : Antibiotics and Bacterial Infection S 17

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection - A Real-World Cohort Study

Efficacy analysis of HAART in 52 cases o hemophilia with HIV/HCV coinfection

Human brain atlas: For high‐resolution functional and anatomical mapping

Four years clinical analysis of 50 cases of hemophilia patients co-infected by AIDS/HCV treated with active antiretroviral therapy

Efficacy Analysis of HAART in 52 Cases of Hemophilia with HIV/HCV Coinfection

[The Efficacy and Prognostic Predictors of Different Treatment Courses with Pegylated Interferon Α-2A and Ribavirin Combination in Recurrent Chronic Hepatitis C Patients].

Therapeutic dilemmas in management of cystine calculi.

Antiretroviral Therapy, Interferon Sensitivity, and Virologic Setpoint in Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Patients

Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study